{
    "clinical_study": {
        "@rank": "85702", 
        "acronym": "SERODIFF", 
        "arm_group": [
            {
                "arm_group_label": "Case", 
                "arm_group_type": "Experimental", 
                "description": "Hospitalized patient with clinical signs of Clostridium Difficile Infection and specific detection in stools of Clostridium Difficile toxins"
            }, 
            {
                "arm_group_label": "Diarrheal control", 
                "arm_group_type": "Other", 
                "description": "Hospitalized patient with clinical signs of Clostridium Difficile Infection without detection in stools of Clostridium Difficile toxins"
            }, 
            {
                "arm_group_label": "Non-diarrheal control", 
                "arm_group_type": "Other", 
                "description": "Hospitalized patient and asymptomatic carrier of Clostridium Difficile"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis: the antibody directed against certain antigens of Clostridium difficile would be\n      predict the Clostridium difficile infection.\n\n      This study evaluates the weight of immunity by studying patients with Clostridium difficile\n      infection versus controls (each patient is associated with two controls : diarrheal control\n      without Clostridium difficile, and non-diarrheal control with or without Clostridium\n      difficile). Recurrence and the kinetics of imunitaire response following infection\n      Clostridium difficile are studied by following the patients during three months.\n\n      There are also building biological samples collections clinically documented: sera, stool\n      and strains."
        }, 
        "brief_title": "CHV 11/51 - SERODIFF", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Clostridium Difficile Infection", 
        "condition_browse": {
            "mesh_term": "Clostridium Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "CASES :\n\n        Inclusion criterias of the cases :\n\n          -  Hospitalized patients with clinical signs of Clostridium Difficile Infection and\n             specific detection in stools of Clostridium Difficile toxins or/and isolating in\n             stools and by digestive biopsy a  strain producer of Clostridium Difficile toxins.\n\n          -  Patients for which a serum prior to the episode of Clostridium Difficile Infection ,\n             ideally as far as possible of the episode, but at least 6 days before the day of\n             diagnosis (D0) will be available.\n\n          -  Patients for which consent has been signed or by their legal representative by\n             default.\n\n          -  Patients for whom it is found one or history of Clostridium Difficile Infection in\n             their file surgical and those for whom Clostridium Difficile Infection is the reason\n             for admission will be included in the study but will be subject of a separate\n             analysis, and their witnesses.\n\n        Exclusion criterias of the cases :\n\n          -  Eligible patients for whom Clostridium Difficile Infection has been strongly\n             suspected clinically but for which no microbiological confirmation will have been\n             obtained.\n\n          -  Eligible patients for whom no previous serum will have been recovered according to\n             the criteria and conditions. The availability of a serum corresponding to the\n             patient's admission is optional and can not be an exclusion criteria.\n\n          -  Eligible patients (or their legal representatives) who are opposed to the use of\n             their samples,the achieving samples and/or the longitudinal follow-up.\n\n          -  Eligible patients who underwent plasmapheresis or treated with monoclonal antibodies\n             to toxin A and B or immunoglobulins during the year preceding the episode of\n             Clostridium Difficile Infection.\n\n          -  Eligible patients but already  included in the study for a recent infection with\n             Clostridium Difficile or transferred to a second health facility for the same episode\n             of Clostridium Difficile Infection.\n\n          -  Eligible patients whose physicians responsible for the management refused\n             participation in the study.\n\n          -  Protected persons: pregnant women and children under the age of 18.\n\n        Secondarily be excluded the following cases:\n\n          -  Patients for whom no sample has been achieved or retained by the laboratory of\n             Medical Biology who participated in the diagnosis and monitoring of the patient.\n\n          -  Hospitalized patients at the time of Clostridium Difficile Infection suspicion and\n             diagnostic sample but released or transferred before rendering necessary\n             microbiological results at baseline (D0 or D3).\n\n          -  Matched control in a case excluded will be excluded.\n\n        NON-DIARRHEAL CONTROL : Eligible patients are those who do not have diarrhea at the time\n        of recruitment.\n\n        To ensure that exposure to risks similar for cases and controls (hospitalization, usually\n        care epidemic period, ...) will be recruited eligible patients according to the following\n        criteria:\n\n          -  Within a maximum period of three months after the inclusion of cases.\n\n          -  Hospitalized in the same hospitalization service type as the case.\n\n          -  With a duration of prior hospitalization at least as long as the time between\n             admission and the corresponding case D0,\n\n          -  Matched on sex and three age categories (20-40, 41-60 and> 60 years).\n\n        The inclusion of these controls depends on the one hand signing an informed consent for\n        participation in the study and secondly the lack clinical signs suggestive of Clostridium\n        Difficile Infection at the time of inclusion and known history of Clostridium Difficile\n        Infection in their medical records (one non-diarrhea control hospitalized ND) for one\n        case).\n\n        DIARRHEAL CONTROL: Eligible patients are those for which a specific search toxins of\n        Clostridium Difficile and/or culture of Clostridium Difficile in stool are found negative\n        (other causes of diarrhea). The patient will be followed for 7 days to rule definitively\n        causality Clostridium Difficile diarrhea and validate his recruitment\n\n        To ensure that exposure to risks similar for cases and controls (hospitalization, usually\n        care epidemic period, ...) will be recruited eligible patients according to the following\n        criteria:\n\n          -  Within a maximum period of three months after the inclusion of cases.\n\n          -  Hospitalized in the same hospitalization service type as the case.\n\n          -  With a duration of prior hospitalization at least as long as the time between\n             admission and the corresponding case D0,\n\n          -  Matched on sex and three age categories (20-40, 41-60 and> 60 years).\n\n        The inclusion of these controls depend on the one hand signing an informed consent for\n        participation in the study and secondly the lack known history of Clostridium Difficile\n        Infection in their medical records (one control hospitalized diarrheal control(D) for one\n        case)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946750", 
            "org_study_id": "RCB : 2012-A00224-39"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Case", 
                    "Diarrheal control", 
                    "Non-diarrheal control"
                ], 
                "intervention_name": "Serum", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": [
                    "Case", 
                    "Non-diarrheal control"
                ], 
                "intervention_name": "Stools", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 17, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bondy", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Jean Verdier"
                }, 
                "investigator": {
                    "last_name": "Isabelle DURAND", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France"
                    }, 
                    "name": "HCL - H\u00f4pital Edouard HERRIOT"
                }, 
                "investigator": {
                    "last_name": "Philippe VANHEMS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France"
                    }, 
                    "name": "CHRU de Montpellier - H\u00f4pital Arnaud de Villeneuve"
                }, 
                "investigator": {
                    "last_name": "Anne LOTTHE", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Central de Nancy"
                }, 
                "investigator": {
                    "last_name": "Francine MORY", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France"
                    }, 
                    "name": "CHU de Nice - H\u00f4pital de l'Archet"
                }, 
                "investigator": {
                    "last_name": "Luce LANDRAUD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Saint Antoine"
                }, 
                "investigator": {
                    "last_name": "Laurent BEAUGERIE", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Lariboisi\u00e8re"
                }, 
                "investigator": {
                    "last_name": "Jean-Michel GUERIN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Groupe Hospitalier Paris Saint Joseph"
                }, 
                "investigator": {
                    "last_name": "Carine COUZIGOU", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France"
                    }, 
                    "name": "CHU de Poitiers - H\u00f4pital de La Miletrie"
                }, 
                "investigator": {
                    "last_name": "Christophe BURUCOA", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France"
                    }, 
                    "name": "CHU de Reims - H\u00f4pital Robert Debr\u00e9"
                }, 
                "investigator": {
                    "last_name": "Odile BAJOLET", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France"
                    }, 
                    "name": "CHU de Rouen - H\u00f4pital Charles Nicolle"
                }, 
                "investigator": {
                    "last_name": "Ludovic LEMEE", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France"
                    }, 
                    "name": "CHU de Toulouse - H\u00f4pital Purpan"
                }, 
                "investigator": {
                    "last_name": "Delphine BONNET", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tourcoing", 
                        "country": "France"
                    }, 
                    "name": "CH de Tourcoing - H\u00f4pital Gustave Dron"
                }, 
                "investigator": {
                    "last_name": "Hugues MELLIEZ", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valenciennes", 
                        "country": "France"
                    }, 
                    "name": "CH de Valenciennes"
                }, 
                "investigator": {
                    "last_name": "Arnaud BORUCHOWICZ", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Versailles", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier de Versailles"
                }, 
                "investigator": {
                    "last_name": "Alix GREDER-BELAN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections", 
        "overall_contact": {
            "email": "acattenoy@ch-versailles.fr", 
            "last_name": "Amina CATTENOY, Project Manager"
        }, 
        "overall_contact_backup": {
            "email": "lmorisset@ch-versailles.fr", 
            "last_name": "Laure MORISSET, Project Manager"
        }, 
        "overall_official": [
            {
                "affiliation": "Centre hospitalier de versailles", 
                "last_name": "Alban LE MONNIER, Microbiological coordinator", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centre hospitalier de versailles", 
                "last_name": "Alix GREDER-BELAN, Clinical coordinator", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Consider the differential distribution of serum antibody titers, comparing experimental cases's sera prior episodes of Clostridium difficile infection (J-6) and the hospitalized controls's sera (J0).", 
            "measure": "Serum antibody titers", 
            "safety_issue": "Yes", 
            "time_frame": "J-6, J0"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946750"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Central Hospital, Versailles", 
            "investigator_full_name": "Alban LE MONNIER", 
            "investigator_title": "Microbiological coordinator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The sera will be included in the analysis of the kinetics appearance of the immune response.", 
                "measure": "Kinetics of antibody", 
                "safety_issue": "Yes", 
                "time_frame": "J-6, J0, J21, J90 and each recurrence"
            }, 
            {
                "description": "Cases and controls : patients will be followed for 3 months to monitor the clinical evolution (or death) after the  of Clostridium difficile infection episode and determine the occurrence of any recurrence up to 3 months after the diagnosis.", 
                "measure": "Clinical evolution", 
                "safety_issue": "No", 
                "time_frame": "J90"
            }, 
            {
                "description": "Comparison of antibody titers for each antigen will be selected among different population groups formed : patients with Clostridium difficile infection, asymptomatic carriers patients, non-carriers patients including non-diarrheal and diarrheal (diarrhea due to other causes than Clostridium difficile infection).", 
                "measure": "Antibody titers for each antigen selected", 
                "safety_issue": "Yes", 
                "time_frame": "J0"
            }, 
            {
                "description": "Matching of controls on sex, type of service, age and length of hospital stay.", 
                "measure": "Risk factors", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Molecular characterization of strains isolated from patients with Clostridium difficile infection (experimental cases) and recurrence, to confirm microbiologically the notion of recurrence after a previous episode or occurrence of a new episode following infection by a new strain of Clostridium difficile.", 
                "measure": "Molecular typing of Clostridium difficile strains", 
                "safety_issue": "No", 
                "time_frame": "J0 and each recurrence"
            }
        ], 
        "source": "Central Hospital, Versailles", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Institut Pasteur", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Sanofi Pasteur, a Sanofi Company", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Hopital Saint Antoine", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Central Hospital, Versailles", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}